Member Info for zebbo

Interesting article...for those that are interested :-) https://www.epmag.com/efforts-quickly-accelerate-guyana-suriname-basin-1702641

With seven finds in three years, ExxonMobil�s subsidiary, EEPGL has begun its latest quest for more oil here as it last week began drilling a new exploration well named Longtail-1 https://www.stabroeknews.com/2018/news/guyana/05/28/exxon-embarks-on-new-well-drilling/

are mind blowing and the relatively low risk, low cost business model is a peach when compared to other bio / pharmas. We are well behind the value curve when it comes to SP IMHO

Forgot to mention our mkt cap is also v low at c�50M. Take CHAR for example at �40M. A clear disconnect with value at ECO, I guess thats why AO bought in at these levels.

What I am trying to say, is that even without Namibia the investment case is compelling ..:-)

but the investment case remains the same, even without a potential CPR upgrade and parking Namibia to one side. This is a great risk Vs reward play. 3-4 shots in the hottest oil play in town, few clicks up dip from Exxons finds. The CPR data confirms contiguous sands, so also expect a further increase in COS. Stocks can change direction and popularity in an instance, particularly oilies. Just no news / PR at the mo. Ive a good 6 fig holding and more than happy to sit and hold. Not particularly bothered with a few pennies move either way as I expect a lot further uplift in SP by year end given the fact we have been derisked by Exxons work Obviously, timing an entry can be key, but with big moves expected on the upside, I would not worry about the current price drift. Worst case African Oil would probably take us out around 40p (assuming upgraded CPR & Total farm in)

Ive got a shed load of SRO...ha ha feeling this may well test the lows prior to move up

Thanks GW

but cannot understand if there is still a seller about. Also what on earth is going on with Killick Looking to buy in, just trying to join the dots first

of 30p pre results. The question is will we have to wait until Aug (as the last RNS seems to indicate) or will we get an update in July, before results are formalised There are 3 outcomes 1. Outstanding results all objectives met / bettered = possible fund raise and go it alone 2. Good results and we license asap 3. Results not as expected and we make the appropriate changes and re trial After all we know the formula works, its just how it will work, based on the changes made

that we will get a successful trial outcome. Lets not forget we are not developing ground up just tweaking the recipe Then of course we have Nuvec Professional individuals are excited about the potential lack of leakage into the liver with #Nuvec, claiming positive results published proving immunity from fulminant hepatic failure to the end user will awaken the drug world and throw N4 into the pharmaceutical spotlight #N4P

Many times todays mcap. Hard to say. Based on the analysis that N4P conducted with regards vendors stocking N4Ps version as sildenafil. as a preferred product, they would ,if memory serves me correctly take ~25% of the market, which is �4B per yer opportunity

over the coming weeks for really big SP impacting news. Personally thing we will head towards 30p, if not beyond prior to news (if non materialises tomorrow) Big RNSs are rarely released on Fridays, but you never know

First indicators may well have leaked out on the trial

We look forward to providing a further update as soon as we receive the full results which are expected in late August." So may not get anything in July, when provisional results are expected

could send us to a min mkt cap of �50m. I expect the SP to rise over the next 6 weeks may get an early indication though

Picking up some more today, stake building nicely

No surprise, HMI is cheap at the mo and has everything going for it.

If the CPR is v good, I think Total may take ECO out. Not sure what a fair price would be for a prospect CPR on a per barrel basis

the BB bickering. This is a massive opportunity for investors and only going to get bigger, the facts speak for themselves